By doing so, the immunosuppressive tumor microenvironment (TME) was rebuilt with increased tumor‐infiltrated CD8+ T cells (Scheme 1B), and DNDA thus showed enhanced antitumor efficacy in combination with PDL1 antibody in MC38 colon cancer and B16 melanoma animal models. This evidence concerns the gene CD274 and neoplasm.